NewsSource: EClinCloud

2 Days to Go! The Ultimate Event Guide to the EClinCloud User Conference Is Here—Enjoy Chengdu

2 min readEClinCloud Editorial Team
Article illustration

Source: EClinCloud.

Article illustration
EClinCloud First User Conference: "Digital and Intelligent Empowerment · Symbiosis and Win-Win"
Opening soon on September 22
This is a major gathering for exchange on clinical digital intelligence
And also a laid-back, enjoyable industry party
Countdown: 2 days
Please check out this ultimate attendee guide
A step-by-step guide to enjoying Chengdu
Article illustration

Guide 1: Hotel & Transit—Find Your Way Easily

Article illustration

Venue: Niccolo Chengdu 

Article illustration

[Address] Tower 3, International Finance Square (IFS), No. 1 Section 3, Hongxing Road, Jinjiang District, Chengdu, Sichuan

(370 meters from Exit C of Chunxi Road Metro Station)
Article illustration
Article illustration
Article illustration

Guide 2: Explore Nearby—Enjoy Chengdu at Its Best

“

Meet up at Chengdu's trendiest spots, Chunxi Road and Taikoo Li, for a city walk!

Article illustration



Article illustration

“

Check in at the iconic climbing giant panda at IFS—sure you don't want a photo with it?

Article illustration
Article illustration
Article illustration

Guide 3: Generous Prizes Waiting for You

Article illustration

HUAWEI Mate 60 Pro

Article illustration

Fujifilm instax mini 40

Article illustration

National Museum of China Tea Set Gift Box

Article illustration

Tasogare Coffee Gift Box

Article illustration

Golden Peony High-Mountain Organic Tea Gift Box




*As in-person registration is currently full, if you wish to attend in person, please reach out to your organization's designated EClinCloud contact.


Article illustration





About EClinCloud

EClinCloud is a technology company focused on clinical R&D. It provides an integrated, interconnected all-in-one clinical trial cloud platform (covering technology products and solutions such as eCOA, CTMS, eTMF, EDC, RTSM, and RM, including solutions for scale design, scale copyright management, linguistic validation, rater training, and data quality analysis) as well as clinical trial endpoint assessment technologies across therapeutic areas (including central nervous system and ophthalmology). Combining cutting-edge technology with life data, it is building a globally leading patient-centric clinical-evidence-support SaaS cloud platform to help domestic and international pharmaceutical companies and research institutions improve R&D efficiency, accelerate the market launch of drugs and medical devices, and benefit countless patients.




Article illustration




Read the original WeChat article

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.